Alan Meds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.5/10
Best for: compounded semaglutide at one price for every dose, if you can pay two or more months up front
Alan Meds falls below our bar on oversight: the FDA has issued it a warning letter. It charges from $135 a month, paid up front; its compounded semaglutide, at $158, paid up front, is 21% below the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
charged as a multi-month plan up front
microdose tier; standard plans start at $158/mo
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Alan Meds sells compounded semaglutide and tirzepatide as injections, microdoses and oral tablets, plus brand Wegovy, Zepbound and Ozempic. Every advertised price is a prepaid average: injectable semaglutide works out to $158 a month on a two-month plan, tirzepatide to $325 on six months. The price stays the same at every dose. Alan Health Technologies, Inc. runs it, and the FDA warned the company in February 2026.
Is Alan Meds legit?
Alan Meds is a real, operating US company, and the FDA has issued it a warning letter. The letter is summarized at the top of this review. Read what it alleges before you decide, and raise it with the clinician who would prescribe for you. We rate Alan Meds 7.5/10 overall.
Is there an Alan Meds promo or coupon code?
We know of no promo or coupon code for Alan Meds. Its listed price is $135 a month. Coupon sites advertising "Alan Meds discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Alan Meds compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Alan Meds
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
Alan Meds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $135/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Medication · Consult
- Availability
- 46 states
- FDA status
- 1 FDA warning letter (details below)
How Alan Meds scores
Six columns, each one computed from something Alan Meds has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
6.0/10$158/month is 21% below the $199 median for compounded semaglutide across the sellers we compare. Every standard-dose price requires paying for several months up front, so Value is capped at 6. A cheaper microdose price is also listed; Value is scored on the standard dose.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
5.5/10The FDA has issued it a warning letter. No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
9.4/10Serves 46 of 50 states.
Support10%
5.5/10The price covers the medication and clinician visits.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Alan Meds
Last checked October 2026- Checked the listed price across 5 dose or plan tiers
- Checked state coverage: 46 states
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Alan Meds
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Alan Meds involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Alan Meds shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Alan Meds which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication and clinician visits.
- Lowest ongoing monthly price: semaglutide $135, tirzepatide $145. That leaves out membership fees, first-month rates and insurance copays.
- Alan Meds serves 46 of 50 states, so check that yours is one of them.
- The FDA has issued Alan Meds a warning letter. It is covered in the enforcement section below; read what it alleges before you decide.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Alan Meds
- Alan Meds offers email support
Cancelling Alan Meds
Taken from the terms Alan Meds publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None on some plans; longer prepaid plans at a discount
- Refund policy
- All sales final; no refunds or returns on prescription products
- Early-termination fee
- None
Medications Alan Meds lists
Alan Meds lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
Shown as $215 a month against $305.
Check the price yourself before you pay
Every figure here comes from Alan Meds's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $158 a month, 21% below the $199 median for compounded semaglutide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication and clinician visits
- Serves 46 states
Against it
- Tirzepatide costs $325 a month, 21% above the $269 median for compounded tirzepatide across the sellers we compare
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Alan Meds a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Alan Meds charges
Alan Meds charges $135/month for its microdose tier; its standard plans start at $158/month and hold that rate across every dose.
- Compounded semaglutide (injection): $158/month
- Compounded semaglutide (oral): $215/month
- Compounded semaglutide (microdose oral): $135/month
- Compounded tirzepatide (injection): $325/month
- Compounded tirzepatide (microdose injection): $145/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so Alan Meds' $158 is genuinely below the middle, not just advertised that way. Some of Alan Meds' plans are paid several months up front, so read the terms you agree to at checkout before you choose a longer one. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.
Ivim Health, at about $140/month, is the closest like-for-like alternative we review.
What Alan Meds dispenses
Alan Meds prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy. Alan Meds also lists a microdose plan, and the published evidence on GLP-1 microdosing is letters and commentary rather than trials.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Alan Meds at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
Alan Meds tells you its price before you start the medical questionnaire, the 46 states it serves, and that its pharmacy is accredited. The FDA has issued Alan Meds a warning letter, summarized at the top of this page. A letter flags a problem rather than ruling a seller out, so read what it says before deciding what it means for you. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Alan Meds will not tell you, treat that as a warning sign. Across the market, the FDA's GLP-1 warning letters are mostly about what sellers said rather than what pharmacies made. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Alan Meds bills your plan before you start.
- A seller's regulatory history matters to you more than price. Read the warning letter summarized above before deciding.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want the price to stop moving as your dose climbs
- injections are the thing keeping you from starting
Our read
Alan Meds competes on price, and at $158/month for compounded semaglutide it competes well. The FDA warning letter is what to weigh against that, not a footnote to it. Whatever you decide, read the warning letter summarized at the top of this page first, and raise it with the clinician who would prescribe for you.
The Bottom Line
Alan Meds falls below our bar on oversight: the FDA has issued it a warning letter. It charges from $135 a month, paid up front; its compounded semaglutide, at $158, paid up front, is 21% below the $199 median among the sellers we compare.
Before you pay Alan Meds
Starting at $135 a month. Check today's price, then start the intake.
Where Alan Meds is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to Alan Meds sets more sellers in the same category beside Alan Meds on price, states and what the price includes.
Frequently Asked Questions
How to check Alan Meds yourself
- How to Verify an Online GLP-1 Pharmacy: Six Public Checks
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
- How to Get a GLP-1 Prescription
Every seller that ships to your state, side by side: California, Florida, Minnesota, North Carolina, North Dakota, Rhode Island, Texas, Virginia and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Alan Meds has an FDA warning letter on record, dated February 20, 2026
This letter concerns false & misleading claims/misbranded. A warning letter is public correspondence from FDA, not an adjudication. On its own it establishes no finding of illegal activity, and a company that gets one often answers with corrective action.
Sources
Cited across this Alan Meds review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Alan Meds's current pricing
Plans start at $135 a month. Whether you qualify is a clinician's decision, made after your intake.